Two primary cancers appeared after discontinuation of nivolumab in the course of treating Hodgkin lymphoma: a case report.

Autor: Potluri LB; Department of Internal Medicine at Detroit Medical Center/Wayne State University, Sinai Grace Hospital, Detroit, MI, USA., Nanjareddy S; Department of Internal Medicine at Detroit Medical Center/Wayne State University, Sinai Grace Hospital, Detroit, MI, USA., Al Sbihi A; Department of Internal Medicine at St. Mary Mercy Hospital, Livonia, MI, USA., Manasrah N; Department of Internal Medicine at Detroit Medical Center/Wayne State University, Sinai Grace Hospital, Detroit, MI, USA., Smith W 4th; Department of Pathology, Detroit Medical Center/Wayne State University, Detroit, MI, USA., Sano D; Department of Oncology, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: AME case reports [AME Case Rep] 2023 Jul 10; Vol. 7, pp. 30. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).